Rhino dietary supplements are being recalled because they contain undeclared drugs and may be a health hazard. FDA analysis found that the products contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase PDE-5 inhibitor, a class of drugs used to treat male erectile dysfunction, making these products unapproved new drugs. Dapoxetine is an active ingredient not approved by the U.S. Food and Drug Administration (FDA). No reports of adverse effects have been received to date.
Desmethyl carbondenafil can interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to life-threatening levels. Dapoxetine has not been approved for use by the FDA. This chemical is an SSRI used to treat depression, which can increase the risk of suicidal thinking and ideation in children, young adults, and adolescents.
The recalled items are RHINO 7 3000 capsules in a bottle with six capsules. The UPC number is 616453150126. All lot numbers are recalled. Also recalled is Rhino 7 Platinum 3000 Capsules packaged in a single blister pack with hang card count UPC number 700729253748. Lot numbers are on the back top right of the one count product and on the side of the six count bottle. In addition, National Video Supply in Santa Clarita, California is recalling the single 1 count blister packs of RHINO 7 3000 Platinum Capsules.
Premiere Sales Group has discontinued the sale of these products. If you purchased these products, do not consume them. Discard or return to the place of purchase for a refund.
If you have experienced adverse effects after taking these products, you can report it to the FDA. Fill out the online form at MedWatch Reporting Form.
